Composition for impotence and premature ejaculation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 北京元延医药科技股份有限公司
- Publication Date
- 2015-04-01
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a pharmaceutical composition for treating impotence and premature ejaculation, in particular, the composition contains avanafil, dapoxetine or a pharmaceutically acceptable salt thereof. Background technique
[0002] According to the survey, among the male population aged 18 to 59, 35% of the males suffer from sexual dysfunction. Males suffer from impotence (erectile dysfunction, ED, which usually manifests as inability to erect the penis so that effective sexual intercourse cannot be performed) and premature ejaculation (PE). , usually manifested as too fast ejaculation, especially ejaculation within less than 5 minutes, especially less than 2 minutes, especially less than 1 minute) is the most common, high incidence, multiple recurrences, and often accompanied by occurrence, for The quality of sexual life of couples has a greater impact and is an important factor in male infertility. In recent years, patients with impotence ...